BVF Inc’s BioLineRX BLRX Stock Holding History

BVF Inc’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-42,159	Closed	-$2.77M	–	70
2020 Q3	$2.77M	Hold	42,159	–	–	0.15%	58
2020 Q2	$2.88M	Sell	42,159 -1,167	-3%	-$79.7K	0.18%	52
2020 Q1	$2.31M	Hold	43,326	–	–	0.21%	50
2019 Q4	$3.9M	Hold	43,326	–	–	0.3%	46
2019 Q3	$4.58M	Hold	43,326	–	–	0.48%	45
2019 Q2	$9.49M	Hold	43,326	–	–	1.04%	31
2019 Q1	$11.2M	Hold	43,326	–	–	1.25%	26
2018 Q4	$11.4M	Hold	43,326	–	–	1.49%	23
2018 Q3	$27.8M	Hold	43,326	–	–	2.44%	13
2018 Q2	$23.5M	Hold	43,326	–	–	2.3%	17
2018 Q1	$22.6M	Hold	43,326	–	–	2.29%	16
2017 Q4	$28.3M	Hold	43,326	–	–	3.42%	8
2017 Q3	$29.1M	Buy	43,326 +14,159	+49%	+$8.79M	3.7%	10
2017 Q2	$14.9M	Hold	29,167	–	–	2.31%	15
2017 Q1	$16.8M	Buy	+29,167	New	+$18.8M	2.86%	11
2015 Q2	–	Sell	-2,502	Closed	-$3.17M	–	31
2015 Q1	$3.17M	Hold	2,502	–	–	0.66%	22
2014 Q4	$2.43M	Hold	2,502	–	–	0.47%	24
2014 Q3	$2.31M	Hold	2,502	–	–	0.48%	22
2014 Q2	$3.12M	Buy	2,502 +1,169	+88%	+$1.46M	0.49%	19
2014 Q1	$1.78M	Buy	+1,333	New	+$2.19M	0.28%	23

Other funds holding BLRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

BVF Inc's BLRX Position: Q4 2020 in Review

BVF Inc sold out of BioLineRX (BLRX) in Q4 2020, closing a stake of 42,159 shares — an estimated $2.77M sold.

BVF Inc first reported a position in BLRX in Q1 2014 and held it in 20 quarters. The position peaked at $29.1M in Q3 2017. 21 funds tracked by Wall St. Rank hold BLRX as of Q4 2020.

BVF Inc reported no remaining BioLineRX position as of Q4 2020 after selling out during the quarter.
BVF Inc sold 42,159 BioLineRX shares in Q4 2020, an estimated $2.77M.
BVF Inc first reported a position in BioLineRX in Q1 2014 and held it in 20 quarters.
BVF Inc's BioLineRX position peaked at $29.1M in Q3 2017.
21 funds tracked by Wall St. Rank held BioLineRX as of Q4 2020.

Based on BVF Inc's 13F filing for Q4 2020, filed 12 Feb 2021.